In this review article, we will describe the current understanding and ongoing studies on the pathophysiology of Childhood-Onset Dystonia-Parkinsonism in SLC39A14 mutation carriers and new knowledge gained from the availability of experimental animal models with global deletion of the Slc39a14 gene. The gene discussed is SLC39A14; the disease is Parkinsonism.